The pattern recognition receptor, RAGE (receptor for advanced glycation endproducts), propagates cellular dysfunction in several inflammatory disorders and diabetes. Here we show that RAGE functions as an endothelial adhesion receptor promoting leukocyte recruitment. In an animal model of thioglycollate-induced acute peritonitis, leukocyte recruitment was significantly impaired in RAGE-deficient mice as opposed to wild-type mice. In diabetic wild-type mice we observed enhanced leukocyte recruitment to the inflamed peritoneum as compared with nondiabetic wild-type mice; this phenomenon was attributed to RAGE as it was abrogated in the presence of soluble RAGE and was absent in diabetic RAGE-deficient mice. In vitro, RAGE-dependent leukocyte adhesion to endothelial cells was mediated by a direct interaction of RAGE with the β2-integrin Mac-1 and, to a lower extent, with p150,95 but not with LFA-1 or with β1-integrins. The RAGE–Mac-1 interaction was augmented by the proinflammatory RAGE-ligand, S100-protein. These results were corroborated by analysis of cells transfected with different heterodimeric β2-integrins, by using RAGE-transfected cells, and by using purified proteins. The RAGE–Mac-1 interaction defines a novel pathway of leukocyte recruitment relevant in inflammatory disorders associated with increased RAGE expression, such as in diabetes, and could provide the basis for the development of novel therapeutic applications.
Skip Nav Destination
Article navigation
17 November 2003
Article|
November 17 2003
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins : A Novel Pathway for Inflammatory Cell Recruitment
Triantafyllos Chavakis,
Triantafyllos Chavakis
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Search for other works by this author on:
Angelika Bierhaus,
Angelika Bierhaus
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Search for other works by this author on:
Nadia Al-Fakhri,
Nadia Al-Fakhri
5Institute for Clinical Chemistry, Justus-Liebig-University, D-35392 Giessen, Germany
Search for other works by this author on:
Darius Schneider,
Darius Schneider
3Third Department of Internal Medicine, Justus-Liebig-University, D-35392 Giessen, Germany
Search for other works by this author on:
Steffen Witte,
Steffen Witte
2Institute for Medical Biometry and Informatics, University Heidelberg, D-69120 Heidelberg, Germany
Search for other works by this author on:
Thomas Linn,
Thomas Linn
3Third Department of Internal Medicine, Justus-Liebig-University, D-35392 Giessen, Germany
Search for other works by this author on:
Mariko Nagashima,
Mariko Nagashima
7Berlex Biosciences, Richmond, CA 94806
Search for other works by this author on:
John Morser,
John Morser
7Berlex Biosciences, Richmond, CA 94806
Search for other works by this author on:
Bernd Arnold,
Bernd Arnold
6Department of Molecular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany
Search for other works by this author on:
Klaus T. Preissner,
Klaus T. Preissner
4Institute for Biochemistry, Justus-Liebig-University, D-35392 Giessen, Germany
Search for other works by this author on:
Peter P. Nawroth
Peter P. Nawroth
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Search for other works by this author on:
Triantafyllos Chavakis
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Angelika Bierhaus
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Nadia Al-Fakhri
5Institute for Clinical Chemistry, Justus-Liebig-University, D-35392 Giessen, Germany
Darius Schneider
3Third Department of Internal Medicine, Justus-Liebig-University, D-35392 Giessen, Germany
Steffen Witte
2Institute for Medical Biometry and Informatics, University Heidelberg, D-69120 Heidelberg, Germany
Thomas Linn
3Third Department of Internal Medicine, Justus-Liebig-University, D-35392 Giessen, Germany
Mariko Nagashima
7Berlex Biosciences, Richmond, CA 94806
John Morser
7Berlex Biosciences, Richmond, CA 94806
Bernd Arnold
6Department of Molecular Immunology, German Cancer Research Center, D-69120 Heidelberg, Germany
Klaus T. Preissner
4Institute for Biochemistry, Justus-Liebig-University, D-35392 Giessen, Germany
Peter P. Nawroth
1Department of Internal Medicine I, University Heidelberg, D-69115 Heidelberg, Germany
Address correspondence to Dr. T. Chavakis, Department of Internal Medicine I, University Heidelberg, Bergheimer Strasse 58, D-69115 Heidelberg, Germany. Phone: 49-6221-5638603; Fax: 49-6221-564101. email: [email protected]
Abbreviations used in this paper: AGE, advanced glycation endproducts; CML, (carboxymethyl)-lysine; FBG, fibrinogen; FN, fibronectin; HK, high molecular weight kininogen; HUVEC, human umbilical vein endothelial cells; RAGE, receptor for AGE.
Received:
May 14 2003
Accepted:
August 22 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (10): 1507–1515.
Article history
Received:
May 14 2003
Accepted:
August 22 2003
Citation
Triantafyllos Chavakis, Angelika Bierhaus, Nadia Al-Fakhri, Darius Schneider, Steffen Witte, Thomas Linn, Mariko Nagashima, John Morser, Bernd Arnold, Klaus T. Preissner, Peter P. Nawroth; The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins : A Novel Pathway for Inflammatory Cell Recruitment . J Exp Med 17 November 2003; 198 (10): 1507–1515. doi: https://doi.org/10.1084/jem.20030800
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement